Onconova Therapeutics Inc (NASDAQ:ONTX)
| 1.23 Delayed Data As of 3:23pm ET |  -0.19 / -13.38%Today’s Change | 0.62 Today|||52-Week Range 2.04 | +90.49% Year-to-Date |
Latest ONTX News | Press Releases
No recent news for Onconova Therapeutics Inc.
Today’s Trading
| Previous close | 1.42 |
| Today’s open | 1.41 |
| Day’s range | 1.22 - 1.46 |
| Volume | 5,089 |
| Average volume (3 months) | 127,814 |
| Market cap | $17.8M |
Data as of 3:23pm ET, 02/02/2023
Growth & Valuation
| Earnings growth (last year) | +55.71% |
| Earnings growth (this year) | +3.65% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -2.16% |
| P/E ratio | NM |
| Price/Sales | 189.92 |
| Price/Book | 0.39 |
Competitors
Data as of 3:59pm ET, 02/02/2023
Financials
| Next reporting date | March 28, 2023 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $226.0K |
| Annual profit (last year) | -$16.2M |
| Net profit margin | -7,151.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newtown, Pennsylvania |
Forecasts
